Sponsor or institution

Clinical trials and research at The George Institute

• 13Clinical trials
• 1New in 30 days
• 7Countries

Newest trials

All recruiting trials (13)

• Adjunctive Fludrocortisone in Septic Shock on Hydrocortisone

  In septic shock, this trial tests whether adding fludrocortisone (50 mcg or 100 mcg daily) to hydrocortisone improves survival and recovery compared with placebo.

  Recruiting at 2 sites Phase 3 The George Institute · Penrith, New South Wales and 7 other locations · NCT07898462

• Continuing versus stopping aspirin during non-surgical management of chronic subdural hematoma

  This test tries to see if continuing aspirin or stopping it is safer and leads to better outcomes for adults with chronic subdural hematoma who are being treated without surgery.

  Recruiting at 2 sites The George Institute · Beijing and 1 other locations · NCT07240454

• INTERACT4 Expansion: Seeing if a quick GFAP test can help ID brain bleeds before hospital care

  This observational study tests whether a point-of-care GFAP test in pre-hospital care can help identify intracerebral hemorrhage in adults with suspected acute stroke.

  Recruiting at 5 sites The George Institute · Sydney, New South Wales and 5 other locations · NCT07231315

• Non-invasive craniocervical lymphatic drainage to improve memory and thinking after sleep loss

  This trial will try a gentle, non-invasive craniocervical lymphatic drainage technique to see if it improves memory and thinking in adults who are sleep-deprived.

  Recruiting The George Institute · Tianjin · NCT07084701

• Preventing early ventilator infections after severe brain injury

  This will test whether giving a single dose of the antibiotic ceftriaxone soon after starting mechanical ventilation can prevent lung infections and help adults with severe acute brain injury survive.

  Recruiting at 6 sites Phase 3 The George Institute · Canberra, Australian Capital Territory and 28 other locations · NCT06819592

• Comparing treatments for acute intracerebral hemorrhage to prevent secondary brain injury

  This study is testing if giving certain medications early can help prevent further brain damage in people with a type of bleeding in the brain.

  Recruiting Phase 3 The George Institute · Sydney, New South Wales and 1 other locations · NCT06763055

• Fludrocortisone for adults with aneurysmal subarachnoid hemorrhage

  This trial tests whether giving early enteral fludrocortisone to adults hospitalized with aneurysmal subarachnoid hemorrhage reduces death and long-term disability at six months.

  Recruiting at 2 sites Phase 2 The George Institute · New Lambton Heights, New South Wales and 15 other locations · NCT06409364

• Global trial to find effective treatments for stroke

  This study is testing different treatments for stroke patients to see which ones work best to improve their recovery.

  Recruiting at 2 sites Phase 3 The George Institute · Sydney, New South Wales and 1 other locations · NCT06352632

• Comparing blood pressure management strategies after stroke treatment

  This study is testing different ways to manage blood pressure in stroke patients who have had a specific treatment to see which method helps them recover better and reduces risks.

  Recruiting at 2 sites The George Institute · Sydney, New South Wales and 1 other locations · NCT06352619

• Comparing two forms of ketamine for treatment-resistant depression

  This study is testing which form of ketamine, Spravato® or racemic ketamine, works better for people with treatment-resistant depression.

  Recruiting at 7 sites Phase 4 The George Institute · Camperdown, New South Wales and 6 other locations · NCT06278779

• Investigating treatments for chronic kidney disease

  This study is testing different treatments for chronic kidney disease to see which ones can help slow down the disease and prevent kidney failure.

  Recruiting at 49 sites Phase 3 The George Institute · Garran, Australian Capital Territory and 50 other locations · NCT06058585

• Enhanced neurostimulation for treating anorexia nervosa

  This study is testing two brain stimulation treatments to see if they can help people with anorexia nervosa feel better and improve their eating habits.

  Recruiting The George Institute · Sydney, New South Wales · NCT05788042

• Using SGLT2 inhibitors to prevent kidney decline in Type 2 Diabetes

  This study is testing whether a new diabetes medication called dapagliflozin can better prevent kidney problems compared to the standard treatment metformin for people with Type 2 Diabetes.

  Recruiting at 6 sites Phase 3 The George Institute · Sydney, New South Wales and 7 other locations · NCT05345327

Quick answers

How many clinical trials run by The George Institute are recruiting right now?

13, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in Australia (11 trials), China (3 trials), New Zealand (3 trials), Canada (3 trials), Sri Lanka (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 6, Phase 4: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →